Drug companies and bio equivalent test institutes called for retest.

A public hearing took place on May 15 afternoon at the KFDA conference room over 9 products which were cancelled of its registration on charge of manipulated tests in attendance of the representatives from the subjected drug companies and test institutes. In the meeting most of subjected drug companies and other bio equivalency test institutes called for the retests or the withdrawal of its reg...